{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:29:15Z","timestamp":1772166555208,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03558-4","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T17:38:41Z","timestamp":1764697121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A population-based analysis of a risk stratification system for predicting radiotherapy benefits in invasive breast carcinoma of no special type with medullary pattern"],"prefix":"10.1186","volume":"31","author":[{"given":"Jian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanqun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"3","key":"3558_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"3558_CR2","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/1097-0142(197710)40:4<1365::AID-CNCR2820400402>3.0.CO;2-N","volume":"40","author":"RL Ridolfi","year":"1977","unstructured":"Ridolfi RL, Rosen PP, Port A, Kinne D, Mik\u00e9 V. Medullary carcinoma of the breast: a clinicopathologic study with 10\u00a0year follow-up. Cancer. 1977;40(4):1365\u201385.","journal-title":"Cancer"},{"issue":"2","key":"3558_CR3","first-page":"432","volume":"18","author":"MP Budzik","year":"2022","unstructured":"Budzik MP, Sobieraj MT, Sobol M, Patera J, Czerw A, Depta\u0142a A, et al. Medullary breast cancer is a predominantly triple-negative breast cancer\u2014histopathological analysis and comparison with invasive ductal breast cancer. Arch Med Sci. 2022;18(2):432\u20139.","journal-title":"Arch Med Sci"},{"issue":"2","key":"3558_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/his.14091","volume":"77","author":"PH Tan","year":"2020","unstructured":"Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, et al. The 2019 World Health Organization classification of tumours of the breast. Histopathology. 2020;77(2):181\u20135.","journal-title":"Histopathology"},{"issue":"9","key":"3558_CR5","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1158\/0008-5472.CAN-06-0031","volume":"66","author":"F Bertucci","year":"2006","unstructured":"Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Mamessier E, Ad\u00e9la\u00efde J, et al. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res. 2006;66(9):4636\u201344.","journal-title":"Cancer Res"},{"issue":"4","key":"3558_CR6","first-page":"365","volume":"43","author":"VM Zangouri","year":"2018","unstructured":"Zangouri VM, Akrami MM, Tahmasebi SM, Talei AM, Ghaeini Hesarooeih AM. Medullary breast carcinoma and invasive ductal carcinoma: a review study. Iran J Med Sci. 2018;43(4):365\u201371.","journal-title":"Iran J Med Sci"},{"issue":"11","key":"3558_CR7","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1093\/annonc\/mds105","volume":"23","author":"J Huober","year":"2012","unstructured":"Huober J, Gelber S, Goldhirsch A, Coates AS, Viale G, \u00d6hlschlegel C, et al. Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Ann Oncol. 2012;23(11):2843\u201351.","journal-title":"Ann Oncol"},{"key":"3558_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.677207","volume":"11","author":"W Qin","year":"2021","unstructured":"Qin W, Qi F, Guo M, Wang L, Zang YS. Hormone receptor status may impact the survival benefit between medullary breast carcinoma and atypical medullary carcinoma of the breast: a population-based study. Front Oncol. 2021;11:677207.","journal-title":"Front Oncol"},{"issue":"5","key":"3558_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","volume":"22","author":"WJ Gradishar","year":"2024","unstructured":"Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2024;22(5):331\u201357.","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"3558_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.rpor.2013.08.006","volume":"19","author":"C Acevedo","year":"2014","unstructured":"Acevedo C, Amaya C, L\u00f3pez-Guerra JL. Rare breast tumors: review of the literature. Rep Pract Oncol Radiother. 2014;19(4):267\u201374.","journal-title":"Rep Pract Oncol Radiother"},{"issue":"3","key":"3558_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10549-022-06749-3","volume":"196","author":"T Aihara","year":"2022","unstructured":"Aihara T, Kumamaru H, Ishitobi M, Miyashita M, Miyata H, Tamura K, et al. Prognosis and effectiveness of chemotherapy for medullary breast carcinoma. Breast Cancer Res Treat. 2022;196(3):635\u201345.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3558_CR12","doi-asserted-by":"publisher","first-page":"10704","DOI":"10.1038\/s41598-023-37915-2","volume":"13","author":"H Chen","year":"2023","unstructured":"Chen H, Pu S, Wang L, Zhang H, Yan Y, He J, et al. A risk stratification model to predict chemotherapy benefit in medullary carcinoma of the breast: a population-based SEER database. Sci Rep. 2023;13(1):10704.","journal-title":"Sci Rep"},{"issue":"1","key":"3558_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-8140(87)80063-4","volume":"10","author":"A Fourquet","year":"1987","unstructured":"Fourquet A, Vilcoq JR, Zafrani B, Schlienger P, Jullien D, Campana F. Medullary breast carcinoma: the role of radiotherapy as primary treatment. Radiother Oncol. 1987;10(1):1\u20136.","journal-title":"Radiother Oncol"},{"issue":"6","key":"3558_CR14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/tbj.12815","volume":"23","author":"A Stelmach","year":"2017","unstructured":"Stelmach A, Patla A, Skotnicki P, Sas-Korczy\u0144ska B. Typical medullary breast carcinoma: clinical outcomes and treatment results. Breast J. 2017;23(6):770\u20131.","journal-title":"Breast J"},{"issue":"4","key":"3558_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1200\/JOP.777003","volume":"6","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Wolff AC, Mangu PB, Temin S. American society of clinical oncology\/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract. 2010;6(4):195\u20137.","journal-title":"J Oncol Pract"},{"issue":"31","key":"3558_CR16","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society Of Clinical Oncology\/College of American pathologists clinical practice guideline update. J Clin Oncol. 2013;31(31):3997\u20134013.","journal-title":"J Clin Oncol"},{"key":"3558_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.breast.2021.11.015","volume":"60","author":"Z Yang","year":"2021","unstructured":"Yang Z, Li K, Qiu P, Ma Y, Wang B, Yan Y, et al. Research on the cutoff tumor size of omitting radiotherapy for BCSS after breast conserving surgery in women aged 65 years or oder with low-risk invasive breast carcinoma: results based on the SEER database. Breast. 2021;60:287\u201394.","journal-title":"Breast"},{"issue":"3","key":"3558_CR18","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s12032-010-9526-z","volume":"28","author":"SR Martinez","year":"2011","unstructured":"Martinez SR, Beal SH, Canter RJ, Chen SL, Khatri VP, Bold RJ. Medullary carcinoma of the breast: a population-based perspective. Med Oncol. 2011;28(3):738\u201344.","journal-title":"Med Oncol"},{"issue":"11","key":"3558_CR19","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.5858\/133.11.1822","volume":"133","author":"CG Kleer","year":"2009","unstructured":"Kleer CG. Carcinoma of the breast with medullary-like features: diagnostic challenges and relationship with BRCA1 and EZH2 functions. Arch Pathol Lab Med. 2009;133(11):1822\u20135.","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"3558_CR20","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364\u201370.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3558_CR21","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jtcvs.2017.12.107","volume":"155","author":"SY Park","year":"2018","unstructured":"Park SY. Nomogram: an analogue tool to deliver digital knowledge. J Thorac Cardiovasc Surg. 2018;155(4):1793.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"3558_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41523-024-00691-x","volume":"10","author":"A Alfaro","year":"2024","unstructured":"Alfaro A, Catelain C, El-Masri H, Rameau P, Lacroix-Triki M, Scoazec JY, et al. Characterization and spatial distribution of infiltrating lymphocytes in medullary, and lymphocyte-predominant triple negative breast cancers. NPJ Breast Cancer. 2024;10(1):81.","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"3558_CR23","first-page":"205","volume":"38","author":"M Lyndin","year":"2022","unstructured":"Lyndin M, Hyriavenko N, Sikora V, Lyndina Y, Soroka Y, Romaniuk A. Invasive breast carcinoma of no special type with medullary pattern: morphological and immunohistochemical features. Turk Patoloji Derg. 2022;38(3):205\u201312.","journal-title":"Turk Patoloji Derg"},{"issue":"3","key":"3558_CR24","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ijrobp.2010.06.060","volume":"81","author":"CH Park","year":"2011","unstructured":"Park CH, Bonomi M, Cesaretti J, Neugut AI, Wisnivesky JP. Effect of radiotherapy planning complexity on survival of elderly patients with unresected localized lung cancer. Int J Radiat Oncol Biol Phys. 2011;81(3):706\u201311.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"25","key":"3558_CR25","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1200\/JCO.2007.10.9777","volume":"25","author":"JR Carver","year":"2007","unstructured":"Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, et al. American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25(25):3991\u20134008.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3558_CR26","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/annonc\/mdq042","volume":"21","author":"D Hardy","year":"2010","unstructured":"Hardy D, Liu CC, Cormier JN, Xia R, Du XL. Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer. Ann Oncol. 2010;21(9):1825\u201333.","journal-title":"Ann Oncol"},{"issue":"4","key":"3558_CR27","first-page":"223","volume":"23","author":"MR Pfeffer","year":"2017","unstructured":"Pfeffer MR, Blumenfeld P. The changing paradigm of radiotherapy in the elderly population. Cancer J. 2017;23(4):223\u201330.","journal-title":"Cancer J"},{"key":"3558_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fonc.2020.00333","volume":"10","author":"B Li","year":"2020","unstructured":"Li B, Geng R, Wu Q, Yang Q, Sun S, Zhu S, et al. Alterations in immune-related genes as potential marker of prognosis in breast cancer. Front Oncol. 2020;10:333.","journal-title":"Front Oncol"},{"key":"3558_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.humpath.2017.10.020","volume":"70","author":"F Igari","year":"2017","unstructured":"Igari F, Sato E, Horimoto Y, Takahashi Y, Isomura T, Arakawa A, et al. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma. Hum Pathol. 2017;70:129\u201338.","journal-title":"Hum Pathol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03558-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:58:47Z","timestamp":1767711527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03558-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3558"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03558-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6584933\/v1","asserted-by":"object"}]},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"3 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since the SEER database is available to global users, for this type of study formal consent is not required. Therefore, the Ethics Committee of the First Affiliated Hospital of Xi'an Jiaotong University is exempted from review. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No informed consent from patients was required for this study, as the analysis used anonymous data from the SEER database. The authors have signed the SEER database use agreement and obtained permission for access and use of the SEER database.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}